The US-Iran conflict and closure of the Strait of Hormuz is disrupting key shipping routes, causing raw material costs for essential drugs like paracetamol to surge four-fold. This threatens the supply chain for India's pharmaceutical MSMEs, which form 60% of the sector, and could lead to price hikes and quality compromises in government programs like Jan Aushadhi.
Exam Lens
Quick Exam Facts From News
1-Minute Revision
- ›Share of Pharma MSMEs: Nearly 60% of India's 10,500 units
- ›Paracetamol Price Rise: ₹200/kg to ₹800/kg (4-fold)
- ›Target this Data: Nearly 60% of India's 10,500 pharma units are MSMEs.
- ›Target this Nodal Body: Pharmaceutical Export Promotion Council of India (Pharmexcil).
- ›Target this Scheme: Pradhan Mantri Bharatiya Janaushadhi Pariyojana (Jan Aushadhi).
Mastered this topic? Test your knowledge with a full MCQ quiz.
Practice exam-style questions, track your score, and strengthen your recall.